Nobel laureate Carolyn Bertozzi, renowned for her pioneering work in bioorthogonal chemistry, chats with Jorge Conde about her groundbreaking research. They discuss how manipulating chemical reactions in the body can enhance cancer treatment and drug delivery. Carolyn shares her journey through carbohydrate chemistry during the AIDS crisis, highlighting sugars' dual role in immune responses. The conversation also covers the challenges of translating discoveries into market-ready solutions and insights on bridging academia with biotech innovations.
Bioorthogonal chemistry enables targeted research on sugar molecules in cancer cells, enhancing diagnostic and therapeutic strategies against these diseases.
The journey from scientific discovery to market-ready solutions requires strategic planning, funding, and collaboration among researchers and entrepreneurs to improve patient outcomes.
Deep dives
Bioorthogonal Chemistry and Its Impact
Bioorthogonal chemistry plays a crucial role in understanding and targeting cancer cells and immune responses. This innovative approach allows chemical reactions to occur within living organisms without disrupting their biological functions, which Carolyn Bertozzi highlights as instrumental in cancer research. Cancer cells often modify sugar molecules on their surfaces to evade detection by the immune system, thus hiding from immune responses. By developing tools rooted in bioorthogonal chemistry, researchers can investigate these sugars and their functions more effectively, paving the way for targeted therapies and better diagnostics.
Sugars and the Immune System
Complex sugar molecules, or carbohydrates, are essential players in the immune system, influencing how immune cells operate. They assist in guiding immune cells to sites of infection or injury, facilitating the body’s defense mechanisms. Moreover, these sugars can help distinguish between the body's own cells and foreign invaders, forming a critical part of immune recognition. However, in certain diseases like cancer and HIV, these sugars can be exploited by pathogens or tumor cells to evade immune detection, showcasing their dual roles as both protectors and potential adversaries.
Translating Discoveries into Clinical Applications
One major challenge in scientific research is bridging the gap between laboratory discoveries and clinical applications. Carolyn Bertozzi emphasizes navigating this transition, where the focus shifts from basic research to commercialized solutions that can benefit patients. To bring a discovery to the clinic, significant funding, workforce changes, and strategic planning are essential, as traditional academic research frameworks often lack the necessary resources. Key decisions involve determining which discoveries have commercial viability versus those that are better suited for continued academic exploration.
The Genesis of Grace Science
The establishment of Grace Science exemplifies the intersection of personal motivation and scientific innovation in addressing rare diseases. Founded by Matt Wilsey, who sought treatment options for his daughter diagnosed with a genetic disorder related to sugar metabolism, the company represents a collaboration between parents, scientists, and medical professionals. By leveraging Bertozzi's expertise in glycobiology, the company has initiated research into gene therapies, showing promise in developing treatments for conditions previously thought untreatable. This story highlights how passion and collaboration can catalyze significant advancements in medical science, with the potential to improve patient outcomes.
Nobel laureate Carolyn Bertozzi joins Jorge Conde to unravel the concept of bioorthogonal chemistry.
Carolyn traces her pioneering path from early studies in carbohydrate chemistry to how her lab developed the revolutionary ability to manipulate chemical reactions inside the human body.
Together, they highlight the intersection of cutting-edge academic research and the challenges of translating discoveries into market-ready solutions. They also discuss navigating the science-to-startup journey, balancing academic and commercial ambitions, and leveraging precision therapies to address unmet medical needs in cancer and beyond. It’s a compelling case study for founders looking to push the frontiers of biotech.
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode